Exact Sciences Corp (EXAS) Misses Q1 Expectations

Exact Sciences Corp (NASDAQ: EXAS) reported Q1 EPS of ($0.23), $0.04 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $294 thousand versus the consensus estimate of $600 thousand.

For earnings history and earnings-related data on Exact Sciences Corp (EXAS) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'